Log In
Print this Print this

Pexa-Vec, pexastimogene devacirepvec (JX-594, TG6006)

Also known as: JX-5940TG6006

  Manage Alerts
Collapse Summary General Information
Company SillaJen Inc.
DescriptionRecombinant vaccinia virus (addition of GM-CSF and deletion of thymidine kinase)
Molecular Target
Mechanism of ActionOncolytic virus
Therapeutic ModalityActive immunotherapy

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments





 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today